Catalent
CTLT
#1838
Rank
ยฃ8.73 B
Marketcap
ยฃ48.10
Share price
0.00%
Change (1 day)
16.20%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: ยฃ8.73 Billion

On February 19, 2025 Catalent had a market cap of ยฃ8.73 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ8.55 B-6.82%
2024ยฃ9.18 B44.13%
2023ยฃ6.37 B-4.85%
2022ยฃ6.69 B-60.56%
2021ยฃ16.97 B35.02%
2020ยฃ12.57 B100.06%
2019ยฃ6.28 B75.72%
2018ยฃ3.57 B-11.42%
2017ยฃ4.03 B48.16%
2016ยฃ2.72 B29.59%
2015ยฃ2.10 B-5.14%
2014ยฃ2.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ1.95 B-77.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ10.68 B 22.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
ยฃ0.57 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
ยฃ0.60 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA